ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
Onychomycosis as a sociomedical problem: assessment of patients’ quality of life with the modified OnyCOE-T questionnaire

Onychomycosis as a sociomedical problem: assessment of patients’ quality of life with the modified OnyCOE-T questionnaire

Authors:
Екатерина Игоревна Цыганкова,
Виктория Юрьевна Васенова

Журнал: Клиническая дерматология и венерология. 2026;25(1):40-46.

DOI: 10.17116/klinderma20262501140

Read: 1276 раз

Download PDF (RU)Download PDF (EN)

Abstract

Onychomycosis is the most common disease of the nail apparatus in modern dermatological practice. Taking into account the high prevalence, onychomycosis should be considered as a significant sociomedical problem. Moreover, psychosocial limitations associated with onychomycosis have the potential to destructively influence the professional and social activity. Nevertheless, some clinicians tend to consider onychomycosis predominantly as a not medically significant cosmetic defect. A number of validated scales and questionnaires, which allow to objectively assess the impact of onychomycosis on the quality of life of patients as well as treatment efficacy, was developed.

OBJECTIVE

To evaluate the dynamics of quality of life of patients with onychomycosis before and after treatment with photodynamic therapy (PDT) using chlorin-containing photosensitizer (PS) by means of the modified OnyCOE-T questionnaire.

MATERIAL AND METHODS

In an open prospective study, 40 patients with clinically and laboratory verified onychomycosis diagnosis were examined, which were stratified into 2 groups of 20 persons. Patients in the 1st group received PDT with a derivative of chlorin e6 as a photosensitizer, in the 2nd one — combined treatment including PDT and shortened course of systemic antifungal agents. The quality of life was assessed through the modified OnyCOE-T questionnaire before and after treatment.

RESULTS

It has been shown that onychomycosis has a multifactorial effect on the quality of life of patients. It is particularly remarkable that 28 (70%) respondents noted a «severe negative impact» of the disease on the quality of life. Psychological discomfort and functional disorders were the predominant complaints.

CONCLUSION

Despite the absence of vital threats, onychomycosis significantly reduces the quality of life of patients. It seems appropriate to intensify educative activities with regard to the prevention of mycotic infection and modern therapeutic possibilities.

Keywords

  • onychomycosis
  • fungi
  • quality of life
  • questionnaire
  • OnyCOE-T
  • photodynamic therapy

Дата поступления: 17.02.2025

Дата принятия в печать: 05.11.2025

Дата публикации: 16.03.2026

References
  1. Elewski BE, Tosti A. Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical Therapy. J Clin Aesthet Dermatol. 2015;8(11):38-42.
  2. Raznatovsky KI, Rodionov AV, Kotrekhova LP. Dermatomycoses. St. Petersburg: SPbMAPO Publishing House; 2006. (In Russ.).
  3. Gupta AK, Mays RR. The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature. Skin Appendage Disord. 2018;4(4):208-216. https://doi.org/10.1159/000485632
  4. Rustamkhanova GR, Khismatullina ZR, Vlasova NA, Hashimova DT. Assessment of the quality of life in patients with onychomycosis and mycosis of the feet with concomitant non-alcoholic fatty liver disease on the background of complex therapy. Bulletin of Dermatology and Venereology. 2024; 100(1):47-55. (In Russ.). https://doi.org/10.25208/vdv13731
  5. Lateur N. Onychomycosis: beyond cosmetic distress. J Cosmet Dermatol. 2006;5(2):171-177. https://doi.org/10.1111/j.1473-2165.2006.00246.x
  6. Debbagh F, Babokh F, Sbai M, El Mezouari EM, Moutaj R. Impact of onychomycosis on the quality of life of patients. Curr Med Mycol. 2023;9(2):39-44.
  7. Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J. Quality of life of persons with onychomycosis. Qual Life Res. 1993;2(5):341-348. https://doi.org/10.1007/BF00449429
  8. Potter LP, Mathias SD, Raut M, Kianifard F, Tavakkol A. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis. Health Qual Life Outcomes. 2006;4:50.
  9. Gilaberte Y, Robres M, Frias MP, Garcia-Doval I, Rezusta A, Aspiroz C. Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2017;31:347-354.
  10. Warshaw EM, Foster JK, Cham PMH, Grill JP, Chen SC. NailQoL: a quality-of-life instrument for onychomycosis. Int J Dermatol. 2007;46:1279-1286.
  11. Turner RR, Testa MA. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res. 2000;9:39-53.
  12. Sergeev AYu, Sergeev YuV. Fungal infections. A guide for doctors. Moscow: Binom-press; 2003:6-15. (In Russ.).
  13. Kornisheva VG. Photodynamic therapy for onychomycosis (review). Problems of Medical Mycology. 2015;17(1):3-7 (In Russ.).
  14. Szepietowski JC, Reich A, Pacan P, Garlowska E, Baran E. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire. J Eur Acad Dermatol Venereol. 2007;21(4):491-496. https://doi.org/10.1111/j.1468-3083.2006.02004.x
  15. Milobratović D, Janković S, Vukičević J, Marinković J, Janković J, Railić Z. Quality of life in patients with toenail onychomycosis. Mycoses. 2013;56(5): 543-551. https://doi.org/10.1111/myc.12072
slide-cover
slide-cover
slide-cover
slide-cover

Recommended articles:

Clinical and Immunological Phenotypes of Alopecia Areata in Children with Concomitant Atopic Dermatitis: Results of a Cluster Analysis.Russian Journal of Clinical Dermatology and Venereology. 2026;25(4):594-602

The impact of combination therapy for vulvar lichen sclerosus et atrophicus on the quality of life, psychoemotional profile and sexual function of women.Russian Journal of Clinical Dermatology and Venereology. 2026;25(4):561-566

Complications and adverse events of cytoreductive surgery in malignant peritoneal lesions.P.A. Herzen Journal of Oncology. 2026;15(4):68-75

Endoluminal endoscopic surgery in the treatment of patients with early cardioesophageal junction cancer: a comparative analysis with surgical treatment.P.A. Herzen Journal of Oncology. 2026;15(4):7-14

Prevalence of mental disorders and syndromic mental distress in patients with chronic dermatoses: A cross-sectional epidemiological study.S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(7):107-114

The impact of the nasoseptal flap on quality of life after transnasal interventions.Russian Bulletin of Otorhinolaryngology. 2026;91(3):92-99

Prospects for the use of photodynamic therapy in the treatment of resistant forms of onychomycosis.Russian Journal of Clinical Dermatology and Venereology. 2026;25(1):90-94

Comparative assessment of the onychomycosis phototherapy methods efficacy.Russian Journal of Clinical Dermatology and Venereology. 2025;24(3):313-318

Evaluation of blepharoplasty outcomes using psychometric scales.Plastic Surgery and Aesthetic Medicine. 2024;(4-2):72-79

Quality of life and psychosomatic status of women of reproductive age with adenomyosis.Russian Bulletin of Obstetrician-Gynecologist. 2024;24(5):83-89

Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29
  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12
  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru
  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026